{"nctId":"NCT02596451","briefTitle":"To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).","startDateStruct":{"date":"2015-08"},"conditions":["Osteoarthritis"],"count":1164,"armGroups":[{"label":"Diclofenac Sodium gel, 1%","type":"EXPERIMENTAL","interventionNames":["Drug: Diclofenac Sodium gel, 1%"]},{"label":"Voltaren® Gel","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Voltaren® Gel"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Diclofenac Sodium gel, 1%","otherNames":[]},{"name":"Voltaren® Gel","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Healthy male or non-pregnant female aged ≥ 35 years with a clinical diagnosis of OA of the knee according to the American College of Rheumatology (ACR) criteria.\n2. OA Symptoms for at least 6 months prior to screening.\n3. Baseline Western Ontario McMaster Osteoarthritis (WOMAC) pain subscale of \\> 9 on a 20 point scale for the target knee immediately prior to randomization.\n\nExclusion Criteria:\n\n1. History of OA pain in the contralateral knee requiring medication within 1 year prior to screening.\n2. History of secondary OA, rheumatoid arthritis, chronic inflammatory disease (e.g., colitis) or fibromyalgia.\n3. History of gastrointestinal bleeding or peptic ulcer disease.\n4. Known allergy to aspirin or nonsteroidal anti-inflammatory drug (NSAID).\n5. Use of anticoagulants, ACE-inhibitors, cyclosporine, diuretics, lithium, or methotrexate prior to 30 days of screening.\n6. Concomitant use of systemic corticosteroids, topical corticosteroids, or immunosuppressive drugs or their use prior to 30 days of screening.","healthyVolunteers":false,"sex":"ALL","minimumAge":"35 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Absolute Change in the Total WOMAC (Western Ontario and McMaster Universities Arthritis Index) Pain Subscale Score for the Target Knee","description":"The total WOMAC Pain Subscale score was determined by summing the individual scores from each of the five questions using a 5-point Likert scale (i.e., 'none'=0; 'mild'=1, 'moderate'=2; 'severe'=3; 'extreme'=4) comprising the WOMAC Pain Subscale Rating for the Target Knee.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8","spread":"3.96"},{"groupId":"OG001","value":"5.9","spread":"3.94"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":383},"commonTop":["Headache"]}}}